Kruse C, Eiken P, Vestergaard P
Department of Endocrinology, Aalborg University Hospital, Hobrovej 18-22, 9100, Aalborg, Denmark,
Osteoporos Int. 2015 Mar;26(3):1005-16. doi: 10.1007/s00198-014-2973-1. Epub 2014 Dec 3.
UNLABELLED: The association between hyponatremia and osteoporosis was evaluated in humans. A significant association was found between low sodium levels, lower bone mineralization in the hip, and with several common conditions. Hyponatremia could be used as a marker of osteoporosis and systemic disease. INTRODUCTION: The objective of this study was to evaluate the association between hyponatremia and osteoporosis in humans through a cross-sectional study. METHODS: Patient information was gathered from regional and national Danish patient databases, both in- and outpatient settings, from 2004 to 2011. Patients with dual-energy x-ray absorptiometry (DXA) scans performed within this time were included if accompanied [Na+] was measured within 14 days prior or past the scan date. A total of 1575 patients were included. RESULTS: A total of 104 patients were hyponatremic (6.6 %). Total hip and lumbar spine bone mineral content (BMC) and densities (BMD) and T-scores were all significantly lower with hyponatremia. The odds ratio (OR) of osteoporosis significantly increased among hyponatremic patients at both total hip (unadjusted OR = 2.17, 95% CI = [1.40-3.34], p < .05) and lumbar spine (unadjusted OR = 1.83, 95% CI = [1.20-2.80], p < .05) regions. Dose-response found between increasing [Na+] and increasing total hip BMC (slope .174, adjusted p < .05), BMD (slope .004, adjusted p < .05), and T-score (slope .034, adjusted p < .05). Systemic disease was more prevalent in hyponatremia. CONCLUSION: The presence of hyponatremia increases the risk of concurrent osteoporosis at both the total hip and lumbar spine in humans. Hyponatremia could be used a screening tool and marker of secondary osteoporosis.
Osteoporos Int. 2015-3
Osteoporos Int. 2016-3
Osteoporos Int. 2015-9
Osteoporos Int. 2019-1-28
Osteoporos Int. 2006-12
Osteoporos Int. 2017-3
Ther Adv Endocrinol Metab. 2023-9-18
Int Urol Nephrol. 2021-10
Contemp Clin Trials Commun. 2020-6-9
BMC Musculoskelet Disord. 2019-3-4
J Clin Endocrinol Metab. 2014-6-27
Calcif Tissue Int. 2013-9-25
Ren Fail. 2013-7-23
J Clin Endocrinol Metab. 2012-10-17
Intern Med J. 2012-7
Joint Bone Spine. 2011-5-11
J Bone Miner Res. 2011-8
Nephron Physiol. 2010-12-22